Home » Topics » BioWorld Science

BioWorld Science
RSS

New TLR7 agonist prodrugs disclosed by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

April 28, 2020

NantBioScience patents dual Wnt/beta-catenin and hedgehog signaling inhibitors

April 28, 2020

New ROMK blockers identified at Bristol-Myers Squibb

April 28, 2020

Pliant Therapeutics discovers integrin alphavbeta1 and/or alphavbeta6 antagonists

April 28, 2020

Adavosertib shows clinical activity in uterine serous carcinoma

April 28, 2020

Pilot study data for ZX-008 as adjunctive therapy in sunflower syndrome

April 28, 2020

Preclinical data support development of FX-301 for post-operative pain

April 28, 2020

FDA approves Ongentys as add-on treatment for patients with Parkinson's disease

April 28, 2020

Pivotal ADVANCE-1 study of AXS-05 meets primary endpoint

April 28, 2020

FDA grants IND approval for phase III study of GV-971 in Alzheimer's disease

April 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...